Genpact Limited (G)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Genpact Limited.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 12 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 35.20 $ — 37% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
5 of 10 Solid growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 5.1% failed
- More than 10% revenue growth is expected for the coming year 7.3% failed
- Share count grows by less than 3% a year -2.1% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 21.0% failed
- Gross margin at 40% or higher and without meaningful erosion 35.6% failed
- Goodwill from acquisitions does not grow faster than revenue 30.5% passed
- Net debt below twice EBITDA 0.6 x EBITDA passed
- Operating cash flow covers the profits of the last three years 222 m passed
- Return on capital at 15% or higher, or up versus two years ago 17.9% passed
- Insiders hold at least 10% or are net buyers 0.7% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 11.6% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 11
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4.07 | 4.00 – 4.17 | 5,435 | 11.6% | 12 |
| 12/31/2027 | 4.48 | 4.32 – 4.69 | 5,833 | 10.0% | 12 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.85 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.79 | -50.50 | 1,249 | 8.90 | 11.40 | 203 | 183 |
| 2025: Q1 | 0.73 | 14.10 | 1,215 | 7.40 | 10.80 | 40 | 18 |
| 2025: Q2 | 0.75 | 11.20 | 1,254 | 6.60 | 10.60 | 177 | 153 |
| 2025: Q3 | 0.83 | 12.80 | 1,291 | 6.60 | 11.30 | 308 | 292 |
| 2025: Q4 | 0.82 | 4.00 | 1,319 | 5.60 | 10.80 | 287 | 269 |
| 2026: Q1 | 0.86 | 16.80 | 1,296 | 6.70 | 11.40 | -24 | -55 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 2,571 | 341 | 268 | 1.27 | 346 | 1,287 | 2,886 |
| 2017 | 2,737 | 331 | 261 | 1.32 | 359 | 1,424 | 3,450 |
| 2018 | 3,001 | 348 | 281 | 1.45 | 340 | 1,404 | 3,529 |
| 2019 | 3,521 | 429 | 305 | 1.56 | 428 | 1,689 | 4,454 |
| 2020 | 3,709 | 439 | 308 | 1.57 | 584 | 1,834 | 4,874 |
| 2021 | 4,022 | 509 | 369 | 1.91 | 694 | 1,897 | 4,975 |
| 2022 | 4,371 | 502 | 353 | 1.88 | 444 | 1,826 | 4,589 |
| 2023 | 4,477 | 631 | 631 | 3.41 | 491 | 2,248 | 4,806 |
| 2024 | 4,767 | 702 | 514 | 2.85 | 615 | 2,390 | 4,987 |
| 2025 | 5,080 | 760 | 552 | 3.13 | 813 | 2,549 | 5,843 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Genpact Limited bietet Geschäftsprozess-Outsourcing und IT-Dienstleistungen in Indien, dem übrigen Asien, Nord- und Lateinamerika sowie Europa an. Es ist in drei Segmenten tätig: Financial Services; Consumer and Healthcare; und High Tech and Manufacturing.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 145,000 |
| Headquarters | Hamilton, Bermuda |
| Address | Canon's, Court, HM 12 Hamilton, Bermuda |
| Phone | (441) 298-3300 |
| Website | genpact.com |
| IPO Date | 2. Aug 2007 |
| ISIN | BMG3922B1072 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Balkrishan Kalra | CEO, President & Director | 1970 |
| Michael Hal Weiner C.F.A. | Senior VP & CFO | 1972 |
| Piyush Mehta | Senior VP, Chief HR Officer & Country Manager of India | 1969 |
| Riju Vashisht | SVP, Chief Growth Officer, Global Business Leader of Enterprise and Partnerships & Alliances | 1969 |
| Anil Nanduru | Senior VP and Global Business Leader of Consumer, Healthcare & High Tech Software | 1976 |
| Vipin Gairola | Global Operating Officer | – |
| Anthony J. Radesca | Senior VP & Chief Accounting Officer | 1969 |
| Sanjeev Vohra | Chief Technology & Innovation Officer | – |
| Vidya Rao | Chief Information & Transformation Officer | – |
| Kyle Vikstrom | Head of Investor Relations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.